Who owns Invivyd, Inc. (IVVD)? Elite investor 13F holders
2 tracked elite investors reported holding Invivyd, Inc as of 2026-06-30, including Maverick Capital, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Maverick Capital | INVIVYD INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 16550225.00 USD | 18970913.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | INVIVYD INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 868329.00 USD | 995334.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.